World’s Top 45 Companies in Biopharmaceutical Third-party Logistics Market in 2025 Watchlist: Statistical Report (2024–2035)
RELEASE DATE: Aug 2025 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Biopharmaceutical Third-party Logistics Market Size is projected To Grow from USD 146.4 Billion in 2024 to USD 296.5 Billion by 2035, at a CAGR of 6.63% during the forecast period 2025–2035. The growing demand for temperature-sensitive products, technical developments, and the growing globalisation of healthcare are the main drivers of the biopharmaceutical third-party logistics sector's substantial growth prospects
Introduction
The Biopharmaceutical Third-party logistics (3PL) Market Size involves outsourced logistics services specialized for the biopharmaceutical sector. These providers handle warehousing, transportation, and technology to address the complexities of distributing temperature-sensitive, time-critical drugs. Market growth is driven by advanced warehousing technologies like temperature management, mobile cloud solutions, data analytics, real-time tracking, and robotics. With the growing need for specialised logistics in biologics, vaccines, and gene therapies, all of which necessitate stringent cold-chain management and regulatory compliance, the biopharmaceutical third-party logistics (3PL) market is expanding quickly. In 3PL services, cutting-edge technologies, including artificial intelligence (AI), the Internet of Things (IoT), blockchain, mobile cloud solutions, warehouse robotics, and data mining, improve operational efficiency, security, and transparency. To avoid temperature swings, temperature-sensitive products require real-time monitoring with tools like data loggers and smartphone apps like the InTemp CX400. The need for advanced cold chain solutions is further fuelled by the rising demand for vaccines and biologics kept between 2°C and -20°C. By lowering errors and complexity and maintaining product integrity through investments in IoT-enabled sensors and RFID tags, 3PL providers are setting up the biopharmaceutical 3PL market for long-term success.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights - Download the Brochure now and dive deeper into the future of the Biopharmaceutical Third-party Logistics Market.
Biopharmaceutical Third-party Logistics Market Size & Statistics
- The Market Size for Biopharmaceutical Third-party Logistics Was Estimated to be worth USD 146.4 Billion in 2024.
- The Market Size is Going to Expand at a CAGR of 6.63% between 2025 and 2035.
- The Global Biopharmaceutical Third-party Logistics Market Size is anticipated to reach USD 296.5 Billion by 2035.
- North America is expected to generate the highest demand during the forecast period in the Biopharmaceutical Third-party Logistics Market
- Asia Pacific is expected to grow the fastest during the forecast period in the Biopharmaceutical Third-party Logistics Market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the biopharmaceutical third-party logistics market. The increase in rare disease diagnoses in the region and the growing expenditure on research and development. It is anticipated that this factor will lead to an increase in pharmaceutical product sales as well as their import and export. The prevalence of a growing number of illnesses is contributing to the need for biologics and medicines. For example, there is a higher requirement for insulin throughout Asia and the Pacific due to the high prevalence of type 2 diabetes patients in those regions.
North America is expected to generate the highest demand during the forecast period in the biopharmaceutical third-party logistics market. The main factor propelling this industry's expansion is the growing import and export of pharmaceutical chemicals, medications, biologics, vaccines, and other associated goods. This area also has the highest rate of adoption of numerous cutting-edge technologies, and medical care is expensive. As a result, North American pharmaceutical companies are increasingly relying on 3PL service providers to enhance shipping and storage, which is propelling the region's overall growth.
Top 10 trends in the Biopharmaceutical Third-party Logistics Market
- Cold Chain Solutions
- AI & Automation
- IoT & Real-Time Monitoring
- Blockchain Technology
- Cloud-Based Platforms
- Regulatory Compliance
- Sustainability Initiatives
- Personalized Medicine Logistics
- Risk Management
- Advanced Data Analytics
1. Cold Chain Solutions
To preserve effectiveness, temperature-sensitive biopharmaceuticals need careful cold chain management. Modern refrigeration, insulated packaging, and temperature monitoring systems guarantee that goods remain within precise temperature ranges during transportation and storage, preserving patient safety and avoiding spoiling, legal problems, and monetary losses.
2. AI & Automation
Biopharmaceutical logistics are being revolutionised by automation and artificial intelligence, which optimise labour allocation, shipping routes, and warehousing operations. While robotics reduces manual errors, speeds up operations, and lowers costs, AI-driven forecasting increases inventory accuracy and makes it possible to supply essential medications more quickly and reliably.
3. Blockchain Technology
Blockchain technology offers a decentralised, unchangeable ledger that securely documents all biopharmaceutical product movements and transactions. By guaranteeing data accuracy and transparency, this improves traceability, stops counterfeiting, and fosters trust among producers, authorities, and patients.
4. Regulatory Compliance
Globally, the biopharmaceutical supply chain is subject to stringent laws governing paperwork, shipping, and storage. To maintain compliance, lower legal risks, and ensure product safety and efficacy, 3PL providers make investments in quality management systems, employee training, and audits.
5. Personalized Medicine Logistics
Logistics must manage smaller, patient-specific shipments with extreme precision as personalised medicines grow. Strict temperature control, quick delivery, and customised packaging are necessary to guarantee patient safety and treatment efficacy.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the biopharmaceutical third-party logistics market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 11 Companies Leading the Biopharmaceutical Third-party Logistics Market
- FedEx.
- SF Express
- AmerisourceBergen Corporation
- DB Schenker
- KUEHNE + NAGEL
- Kerry Logistics Network Limited
- Agility
- McKesson Corporation
- Nippon Express
- C.H. Robinson Worldwide
- CEVA Logistics
- Others
1. FedEx.
Headquarters: Memphis, Tennessee, USA
With a large network of distribution and transportation services, FedEx Corporation is a global leader in logistics, operating in more than 220 nations and territories. FedEx, which combines cutting-edge technology like artificial intelligence (AI), the Internet of Things (IoT), and real-time tracking to guarantee quick, dependable, and secure shipments, is well-known for its proficiency in express delivery, freight, and supply chain solutions. FedEx is dedicated to sustainability; by 2040, it wants to operate carbon-neutrally by making investments in renewable energy and electric cars. Enhancing product integrity, compliance, and transparency globally, the company provides specialised cold chain services to support biopharmaceutical logistics.
2. SF Express
Headquarters: Shenzhen, China
Leading logistics and express delivery business SF Express is based mostly in China and is growing internationally. It provides full supply chain solutions, including customised services for biopharmaceutical items that are sensitive to temperature. SF Express uses cutting-edge technology, including artificial intelligence (AI), the Internet of Things (IoT), and big data analytics, to improve operating efficiency, tracking precision, and delivery speed. With a dedication to sustainability, the business supports clients in achieving their environmental responsibility and regulatory compliance objectives by concentrating on green logistics projects, including electric cars and eco-friendly packaging.
3. AmerisourceBergen Corporation
Headquarters: Chesterbrook, Pennsylvania, USA
AmerisourceBergen Corporation is a well-known international pharmaceutical sourcing and distribution business with a focus on supply chain and healthcare logistics. It offers a wide range of services, such as data analytics, cold chain management, and speciality medicine distribution, to guarantee the safe and legal delivery of biopharmaceutical goods. AmerisourceBergen uses cutting-edge technology to support regulatory compliance, track shipments in real time, and optimise inventories. Through increasing supply chain efficiency and transparency across global healthcare networks, the organisation is dedicated to sustainability and bettering patient outcomes.
4. DB Schenker
Headquarters: Essen, Germany
Leading global logistics company DB Schenker provides extensive supply chain management and transportation services in over 130 nations. With a focus on biopharmaceutical logistics, it offers real-time tracking, sophisticated cold chain systems, and assistance with regulatory compliance. To maximise effectiveness and transparency, DB Schenker incorporates digital technologies such as IoT and AI. In order to help clients reach environmental and regulatory goals globally, the company is dedicated to sustainability, concentrating on lowering carbon emissions through eco-friendly transportation solutions and green warehousing.
5. McKesson Corporation
Headquarters: Irving, Texas, USA
A major distributor of pharmaceuticals and healthcare services, McKesson Corporation serves pharmacies, hospitals, and healthcare professionals all over the world. It specialises in biopharmaceutical logistics and offers compliance solutions, real-time tracking, and sophisticated cold chain management. McKesson uses state-of-the-art technologies to improve patient safety and supply chain efficiency. As part of its commitment to sustainability, the firm works to provide safe, dependable, and compliant pharmaceutical products to healthcare systems around the world by decreasing its environmental impact through energy-efficient operations and responsible sourcing.
Are you ready to discover more about the Biopharmaceutical Third-party Logistics market?
The report provides an in-depth analysis of the leading companies operating in the global biopharmaceutical third-party logistics market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- FedEx.
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- SF Express
- AmerisourceBergen Corporation
- DB Schenker
- KUEHNE + NAGEL
- Kerry Logistics Network Limited
- Agility
- McKesson Corporation
- Nippon Express
- C.H. Robinson Worldwide
- CEVA Logistics
- Others
Conclusion
The Market for Biopharmaceutical Third-party Logistics (3PL) Market sizeis expanding quickly due to the use of innovative technologies such as blockchain for improved supply chain transparency, AI-powered analytics, and cloud-based platforms for expedited certification procedures. To maintain product integrity and operational effectiveness, businesses are placing a greater emphasis on data-driven verification, automated compliance tracking, and real-time temperature monitoring. Market expansion is increasingly reliant on sustainability initiatives, such as lowering carbon emissions and adhering to ethical sourcing guidelines. The biopharmaceutical industry's need for dependable, creative 3PL solutions that satisfy changing stakeholder expectations and regulatory requirements is being fuelled by the increased emphasis on transparency, adaptability, and ESG compliance.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Follow Us: LinkedIn | Facebook | Twitter
Need help to buy this report?